2023

1. Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration

   Clinical Kidney Journal, Vol. 16, Núm. 11, pp. 2254-2261